Back
Xeris Biopharma Holdings Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
88
XERS
Xeris Biopharma Holdings
Last Price:
3.34
Seasonality Move:
0.46%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.25 | Buy |
| 20-day SMA: | 3.12 | Buy |
| 50-day SMA: | 2.94 | Buy |
| 200-day SMA: | 2.47 | Buy |
| 8-day EMA: | 3.24 | Buy |
| 20-day EMA: | 3.14 | Buy |
| 50-day EMA: | 2.96 | Buy |
| 200-day EMA: | 2.54 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 73.05 | Buy |
| Chaikin Money Flow: | 634179 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.93 - 3.23) | Buy |
| Bollinger Bands (100): | (2.32 - 3.02) | Buy |
Xeris Biopharma Holdings Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 3.34 while XERS 8-day simple moving average is 3.25, which is a Buy signal.
- The stock price of XERS is 3.34 while Xeris Biopharma Holdings 20-day SMA is 3.12, which makes it a Buy.
- Xeris Biopharma Holdings 50-day simple moving average is 2.94 while XERS share price is 3.34, making it a Buy technically.
- XERS stock price is 3.34 and Xeris Biopharma Holdings 200-day simple moving average is 2.47, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
88
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a Buy
The current Xeris Biopharma Holdings [XERS] share price is $3.34. The Score for XERS is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
497.66M
Price in USD:
3.34
Share Volume:
2.22M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
3.39
52-Week Low:
1.46
Buy
88
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?
The Xeris Biopharma Holdings stock price is 3.34 USD today. -
Will XERS stock go up or go down?
Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Xeris Biopharma Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 3.34 while XERS 8-day exponential moving average is 3.24, which is a Buy signal.
- The stock price of XERS is 3.34 while Xeris Biopharma Holdings 20-day EMA is 3.14, which makes it a Buy.
- Xeris Biopharma Holdings 50-day exponential moving average is 2.96 while XERS share price is 3.34, making it a Buy technically.
- XERS stock price is 3.34 and Xeris Biopharma Holdings 200-day simple moving average is 2.54, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.15 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
- XERS Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Xeris Biopharma Holdings is a Buy
- Xeris Biopharma Holdings Relative Strength Index (RSI) is 73.05, which suggest Xeris Biopharma Holdings is overbought
- The Bollinger Bands (25) for Xeris Biopharma Holdings is (2.93 - 3.23), which suggest Xeris Biopharma Holdings is a Buy
- The Bollinger Bands (100) for Xeris Biopharma Holdings is (2.32 - 3.02), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.